Nursing care
Chemotherapy Administration Safety: the method, the errors, and the exam
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Chemotherapy administration safety means two registered nurses independently verify the order against the patient's body surface area, vesicant agents are given only through a patent central line, and personal protective equipment is worn to protect the nurse, not the patient. Every step exists because a single error here can cause tissue necrosis or a fatal overdose.
What the skill is for
Chemotherapy drugs have a narrow margin between a therapeutic dose and a harmful one, and dosing is calculated from body surface area rather than weight alone. A transcription error, a decimal point in the wrong place, or a stale height and weight can turn a correct protocol into an overdose. The double-check exists to catch that before the drug enters the patient, not after.
The skill also protects the nurse. Cytotoxic agents are hazardous drugs: they can be absorbed through skin, inhaled as aerosol, or splashed into the eyes during preparation and administration. Gown, gloves rated for chemotherapy, and eye protection are personal protective equipment for the person giving the drug, not infection control for the person receiving it. That distinction is easy to blur and worth stating plainly.
The method, step by step
Two nurses, both chemotherapy-certified where the institution requires it, independently calculate the ordered dose against the patient's current height, weight, and body surface area, then compare their figures against the order and the pharmacy label before either signs off. This happens away from distraction, not at the bedside with the infusion already primed.
Before the infusion starts, the nurse confirms venous access. A vesicant, an agent capable of causing tissue necrosis if it leaks into surrounding tissue, is never given through a peripheral line for anything beyond a short peripheral protocol; it goes through a central line with confirmed placement and a brisk blood return. The nurse dons chemotherapy-rated gown and gloves before spiking the bag, primes tubing with a non-drug fluid rather than flushing chemotherapy through the air, and disposes of all materials as hazardous waste, not general clinical waste.
Where it goes wrong
The most common failure is a single nurse skipping the independent recalculation and simply co-signing a colleague's number, which defeats the purpose of having two checks. Body surface area itself is a frequent error source: an outdated weight, a transposed height in centimetres versus inches, or a calculator that silently rounds.
The second recurring failure is vesicant extravasation. Warning signs are pain, swelling, or a change in the quality of the blood return at the site, and the drug must be stopped immediately rather than slowed. Nurses who wait to 'see if it settles' allow tissue damage to progress. PPE failures matter too: a nurse who forgets that gloves are for their own protection and handles a spiked bag bare-handed can absorb the drug through skin contact.
Practising it deliberately
Rehearse the body surface area calculation cold, without a reference sheet, until the formula and the units are automatic. Then practise it again with a colleague, each calculating independently from the same height and weight, so the habit of two separate calculations becomes normal rather than a formality.
Run through the vesicant checklist out loud: confirm the line is central, confirm blood return, confirm the drug class before it hangs. Separately, practise identifying which of a list of chemotherapy agents are vesicants versus irritants versus non-vesicants, since exam writers and preceptors both expect that distinction to be recalled instantly.
Applying it on the exam
NCLEX questions on this topic usually present a scenario and ask what the nurse should do first or immediately. If the stem describes swelling, burning, or a sluggish blood return at a vesicant infusion site, the correct first action is to stop the infusion, not to slow it, flush it, or notify the provider first.
Questions also test whether PPE is understood as nurse protection. A stem describing a nurse who declines gloves because 'the patient isn't immunocompromised' is testing whether the candidate knows PPE in this context is about drug exposure to the nurse, unrelated to the patient's infection risk. Watch also for questions that test the two-nurse verification as a discrete step that must occur before the infusion starts, not as something that can be completed retrospectively.
A worked example
A patient is prescribed doxorubicin calculated by body surface area. Nurse A calculates the dose from the patient's charted height and weight and arrives at one figure; Nurse B, without seeing Nurse A's number, calculates independently from the same values. Only when both figures match the pharmacy label does the infusion proceed, through a confirmed central line, with the administering nurse in chemotherapy-rated PPE.
Ten minutes into the infusion, the patient reports burning at the insertion site and the blood return looks sluggish. The correct sequence is to stop the infusion immediately, disconnect the tubing at the hub, aspirate any residual drug from the line if agency protocol directs it, and notify the provider. Continuing the infusion at a slower rate, or waiting to see if the sensation passes, are both wrong answers if this appears as an exam stem.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our med-surg practice questions are the closest set to what this page covers.
One question from the med-surg set
A client with chronic obstructive pulmonary disease has an oxygen saturation of 88% on 2 L/min via nasal cannula and is alert with no distress. What should the nurse do first?
Rationale
In COPD a saturation of 88–92% is the therapeutic target, not an emergency, and this client is alert with no distress. The first action is the independent nursing intervention that is least invasive and most likely to help: sit them up and reassess. Turning the oxygen up to 6 L/min risks blunting the hypoxic drive, and calling rapid response or drawing an ABG escalates ahead of an assessment you have not finished.
Answer: B
Common questions
Why is chemotherapy dosed by body surface area instead of weight?
Body surface area correlates more closely with metabolic rate and drug clearance than weight alone, which narrows the margin of error for drugs with a steep dose-response curve. It is calculated from height and weight together, so an outdated or mistyped value in either figure throws off the final dose.
Can a vesicant ever be given peripherally?
Some institutions permit short peripheral administration of certain vesicants under strict protocols with close monitoring, but this varies by agency and by drug. Where policy allows it, the nurse still checks blood return and site condition continuously and stops at the first sign of infiltration.
Who needs to be chemotherapy-certified to give these drugs?
Requirements vary by state board of nursing and by employer, but most institutions require completion of a chemotherapy and biotherapy course before a nurse administers or double-checks these agents independently. Check your facility's policy rather than assuming certification transfers automatically between employers.
What should the nurse do first if extravasation is suspected?
Stop the infusion immediately and disconnect the tubing at the hub before doing anything else. Do not remove the IV catheter until the institution's extravasation protocol, which may include attempting to aspirate residual drug, has been followed.
More on med-surg